These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 14739148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F, Videla S, Jiménez-Mejías ME, Sirera G, Torre-Cisneros J, Ribera E, Prados D, Clotet B, Sust M, López-Vélez R, Alvar J, Spanish HIV-Leishmania Study Group.
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A.
    J Antimicrob Chemother; 2007 Oct; 60(4):837-42. PubMed ID: 17684055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR.
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
    Sundar S, Goyal AK, Mandal AK, Makharia MK, Singh VP, Murray HW.
    J Assoc Physicians India; 1999 Feb; 47(2):186-8. PubMed ID: 10999086
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR.
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [Abstract] [Full Text] [Related]

  • 9. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH, Dodds Ashley E, Benjamin DK, Duane Davis R, Palmer SM, Perfect JR.
    Transplantation; 2004 Jan 27; 77(2):232-7. PubMed ID: 14742987
    [Abstract] [Full Text] [Related]

  • 10. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May 27; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 11. Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs.
    Krawiec DR, McKiernan BC, Twardock AR, Swenson CE, Itkin RJ, Johnson LR, Kurowsky LK, Marks CA.
    J Am Vet Med Assoc; 1996 Dec 15; 209(12):2073-5. PubMed ID: 8960189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S, Ellis RW, Jones SG, Miller SJ, Fisher NC, Hastings JG, Mutimer DJ.
    Liver Transpl; 2000 Sep 15; 6(5):588-95. PubMed ID: 10980058
    [Abstract] [Full Text] [Related]

  • 14. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S, Mehta H, Suresh AV, Singh SP, Rai M, Murray HW.
    Clin Infect Dis; 2004 Feb 01; 38(3):377-83. PubMed ID: 14727208
    [Abstract] [Full Text] [Related]

  • 15. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP.
    Pharmacotherapy; 1998 Feb 01; 18(4):874-6. PubMed ID: 9692667
    [Abstract] [Full Text] [Related]

  • 16. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP.
    Clin Ther; 2007 Sep 01; 29(9):1980-6. PubMed ID: 18035197
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI, Chandrasekar PH, Hooshmand-Rad R.
    Bone Marrow Transplant; 2005 Nov 01; 36(10):873-7. PubMed ID: 16113663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J, Akard LP, Wack MF, Thompson JM, Dugan MJ, Leslie JK, Mattison R.
    Mycoses; 2006 Sep 01; 49(5):397-404. PubMed ID: 16922792
    [Abstract] [Full Text] [Related]

  • 20. Amphotericin B lipid complex.
    Rapp RP, Gubbins PO, Evans ME.
    Ann Pharmacother; 1997 Oct 01; 31(10):1174-86. PubMed ID: 9337444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.